To investigate which subsets of peripheral blood mononuclear cells (PBMCs) are susceptible to infection with hepatitis C virus (HCV) and hepatitis G virus (HGV) or GB virus C (GBV-C), a PCR-based assay using tagged primers in the core region (HCV) and NS3 region (HGV/GBV-C) for the specific detection of negative strand (replicating) viral RNA sequences was developed. In liver biopsy samples both positive and negative strands of HCV RNA were detected, at levels ranging from 3 to 11i10 6 RNA copies per 10 6 cells and 3n7-4n2i10 3 copies per 10 6 cells respectively, while lower frequencies of positive strands of GBV-C/HGV RNA were detected (from 13 biopsies, the highest frequency was 7n3i10 3 per 10 6 cells). In no samples were negative RNA strands detected. To investigate extra-hepatic
Introduction
Hepatitis C virus (HCV) and the recently identified GB virus C (GBV-C) (Leary et al., 1996 ; Simons et al., 1995) or hepatitis G virus (HGV) (Linnen et al., 1996) are both enveloped viruses that contain single-stranded positive-sense RNA genomes. The genomes are translated into large polyproteins which are subsequently cleaved into various structural and non-structural viral proteins. Virus replication is thought to occur in the cytoplasm of infected cells and involves the synthesis of a negative strand RNA molecule that acts as a template for the production of new positive strands or genomic RNAs by analogy with flaviviruses and pestiviruses. The detection of this negative strand intermediate molecule would therefore be indicative of virus replication.
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replication of HCV and GBV-C/HGV, CD4 M , CD8 M and B lymphocytes, monocytes and putative dendritic cell populations were separated from PBMCs from ten study subjects. Detection of positive strand HCV RNA was largely confined to B lymphocytes (at levels of up to 5i10 3 copies per 10 6 cells), while detection of negative strands was confined to a single subset (dendritic cells) of one of the study individuals. Similarly, GBV-C/HGV was detected at low levels in only twelve of twenty PBMC samples, while negative strands were uniformly absent. The low levels of HCV and GBV-C/HGV RNA in PBMCs suggest that these cells are at most a minor reservoir for virus replication. The absence of detectable replication of GBV-C/HGV suggests that the actual site of GBV-C/HGV replication remains to be discovered.
There have been several reports of detection of replicative intermediates of HCV in liver and also in peripheral blood mononuclear cells (PBMCs) (Lerat et al., 1996 ; Ounanian et al., 1995 ; Moldvay et al., 1994 ; Shindo et al., 1994 ; Willems et al., 1993 Willems et al., , 1994 Muller et al., 1993 ; Zignego et al., 1992 ; Wang et al., 1992 ; Bouffard et al., 1992 ; Fong et al., 1991) . However, many of the findings are conflicting and it is possible that the assays used varied in their specificity in the methods of detection of negative strands of HCV RNA (McGuinness et al., 1994) . Non-specificity in assays for the negative strand of HCV RNA may be attributed to false priming of the incorrect strand, self-priming due to the secondary structure of the 5h non-coding region (5hNCR) of HCV (Lanford et al., 1994) and random priming by contaminating cellular nucleic acids (Gunji et al., 1994) . Using tagged primers in a modified nested PCR for the putative core region of HCV and for the NS3 region of GBV-C\HGV, we have developed a method that allows specific strand detection of single-stranded RNA. The specificity of the assays was assessed by the use of synthetic RNA transcripts for each strand of both viruses, and the sensitivity of the assays was determined by RT-PCR analysis with and without the tagging system.
Using this validated strand-specific RT-PCR we have investigated which, if any, of the circulating PBMC subpopulations contain virus replicative intermediates and therefore serve as possible extra-hepatic sites of replication of HCV and GBV-C\HGV.
Methods
Samples. Twenty ml EDTA-anti-coagulated whole blood was collected from ten individuals with chronic HCV (P1-P10). Patients P1 and P2 were coinfected with GBV-C\HGV. Liver biopsies were collected from P1 and another patient (P11) also chronically coinfected with HCV and GBV-C\HGV, and snap-frozen in liquid nitrogen and stored at k70 mC. A further 11 liver biopsies were collected from GBV-C\HGV-infected individuals (P12-P22). Plasma and PBMC samples were collected from 14 GBV-C\HGV-infected blood donors (P23-P36) and six haemophiliacs (P37-P42) to make up the GBV-C\HGV cohort. A description of the screening of blood donors tested by PCR is in preparation (C. Blair and others, unpublished data) Synthetic HCV and GBV-C/HGV RNA templates. Recombinant positive and negative strand RNAs were generated from a vector (pTAg) containing core and NS3 sequences from HCV (genotype 1b) and GBV-C\HGV respectively. Primers 954 and 410 (positions k54 to 410) for HCV core and primers 3053 and 3052 for GBV-C\HGV (positions 4245-4393 ; Jarvis et al., 1996 ;  Table 1 ) were used to amplify RT-PCR products from the plasma of infected individuals and cloned directly in the plasmid vector (pTAg ; R&D Systems). Clones were selected after RFLP analysis using predicted restriction patterns for sense and antisense orientation of the insert corresponding to positive and negative strands respectively. Confirmatory sequencing of the template DNAs was performed prior to RNA synthesis.
Synthesis of standard RNAs. Five µg of the selected plasmids were linearized using HindIII in a final volume of 50 µl containing the Mellor et al. (1995) . † Primers described by Jarvis et al. (1996) . ‡ Virus-unrelated tag sequence in bold. Nucleotide positions for HCV as in Kato et al. (1990) , and for GBV-C\HGV as in Simons et al. (1995) .
appropriate restriction buffer at 37 mC for 1 h. RNA transcripts were synthesized from 1 µg plasmid by transcription from the upstream T7 RNA polymerase promotor. The DNA plasmid vector was removed via DNaseI digestion (200 µg\ml, 60 min at 37 mC) followed by phenolchloroform extraction and precipitation in ethanol.
RT-PCR Conditions. To maximize the stringency of the reaction conditions, the cDNA reaction mix was heated to 70 mC for 10 min prior to the addition of AMV reverse transcriptase at 42 mC, to pre-denature template RNA. cDNA synthesis was carried out in a 20 µl reaction volume for 30 min at 42 mC as previously described (Chan et al., 1992) . The samples were then heated to 98 mC for 30 min to heat-inactivate the RT, followed by ' hotstart ' PCR with an annealing temperature of 55 mC for 30 cycles. Nested PCR was carried out using primers described in Table 1 , and primers for the 5hNCR region of the viruses previously described (Jarvis et al., 1996 ; Chan et al., 1992) , again with an annealing temperature of 55 mC for 30 cycles. The PCR products were analysed after electrophoresis through a 2 % agarose gel and visualized by staining with ethidium bromide. The different RT-PCR assays were performed simultaneously to avoid degradation of RNA templates on repeated freeze-thawing cycles. A series of specificity controls was included in each round of RT-PCR such as the exclusion of primer for cDNA synthesis as a control for self-priming, the exclusion of reverse transcriptase, and exclusion of template.
Tagging system for strand-specific PCR. In order to overcome the detection of falsely primed cDNA products and make the PCR system strand-specific, an additional 20 nucleotides were added to the 5h end of the outer primers, forming a ' tag '. These ' tag ' sequences were neither complementary nor homologous to any part of the HCV or GBV-C\HGV genome, following the strategy of a similar assay for the detection of hepatitis A virus (Chaves et al., 1994) . PCR amplification of a tagged cDNA was performed using only the tag portion of the cDNA primer as one of the primers and an HCV-or GBV-C\HGV-specific oligonucleotide for the opposing primer. This method yields much greater strand-specificity because it prevents the amplification of falsely primed cDNA products that can be produced in conventional PCR. To amplify negative strand HCV cDNA, primer 379 (Table 1) was used, and
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Replication of HCV in PBMCs
Replication of HCV in PBMCs the antisense primer 380 (primer 410 plus the tag) was used for positive strand synthesis. Primers for the core region were highly conserved between published variants of HCV (Ou et al., 1992 ; Simmonds et al., 1993) . Primers 288 and 289 were used for the positive and negative strand of GBV-C\HGV respectively. For the first round of PCR using 5 µl cDNA in a final volume of 50 µl, the tag sequence alone plus the untagged opposing primer were used, i.e. for HCV negative strands the tag sequence was used as the sense primer and 410 as the antisense primer.
Cell separation. Blood samples were diluted with an equal volume of PBS (Gibco) and mononuclear cells were isolated by centrifugation over discontinuous Ficoll-Hypaque gradients (Lymophoprep, Nycomed). T cells were depleted by rosetting with neuraminidase-treated sheep red blood cells (Scottish Antibody Production Unit), leaving a non-rosetting cell population of B lymphocytes, monocytes, macrophages and cells expressing CD4 and HLA-DR markers (putative dendritic cells). The various cell populations within each fraction were then further subdivided by antibody depletion as previously described (Livingstone et al., 1996) . Briefly, anti-mouse IgG-coated magnetic beads were preincubated with various mouse monoclonal antibodies, which were then used to deplete the ER-positive (rosetting) and ER-negative (non-rosetting) fractions.
Anti-CD4 positively selects T helper cells and anti-CD8 the cytotoxic T cells from the ER-positive fraction. Anti-CD3 removes any contaminating T cells from the ER-negative fraction followed by anti-CD14 for monocytes, anti-CD19 for B cells. Finally, residual cells expressing CD4 and HLA-DR were selected, as this corresponds to the phenotype of dendritic cells (O'Doherty et al., 1993) . Viable cells counts were determined by a haemocytometer for each fraction mentioned.
For four samples (P7-P10), a different method for cell separation was used. PBMCs were incubated with anti-CD14-coated beads (Miltenyi Biotec) and the CD14 population was separated from the remaining PBMCs using a MiniMACS magnetic separation system. CD19, CD4 and CD8 cells populations were isolated from the residual cells using the appropriate monoclonal antibody-conjugated beads. The cell fractions were stored at k70 mC in 10 % DMSO.
Purity of isolated subsets. The process of isolating PBMC subsets by antibody-coated magnetic beads hindered analysis of the selected cells by fluorescence-activated cell sorting (FACS) techniques. However the purity of the cell fractions could be inferred by analysis of the frequencies of different cell types in the residual cell population after the removal of a particular fraction using a FACScan (Becton Dickinson).
Quantification of HCV and GBV-C/HGV sequences. RNA was extracted from the cells and plasma by incubation in proteinase K (1 mg\ml) for 1n5 h at 37 mC in the presence of 0n5 % SDS and poly(A) RNA (40 µg\ml). The nucleic acid was then phenol-chloroform extracted and precipitated with ethanol. RNA was extracted from the liver samples using the guanidinium isothiocyanate method (Chomczynski & Sacchi, 1987) . To estimate the number of cells used for PCR, cell concentrations were compared before and after depletion with specific monoclonals for each subset when using the E-rosetting (ER) method of separation. For the MiniMACS separation method, the cell concentrations were estimated directly from the positive fraction isolated. An estimate of the number of cells in the liver biopsy samples was achieved by estimating the volume of a hepatocyte and estimating the number of cells within the biopsy material available. Semi-quantitative PCR was performed using a previously described limiting dilution method (Simmonds et al., 1990 a, b) . The previously established efficiency of 5 % for the reverse transcription step was assumed in this assay (Hawkins et al., 1997 ; Zhang et al., 1991) .
The quantification results were expressed as the number of copies of HCV or GBV-C\HGV per ml plasma or as the number of copies per 10' cells.
Comparison of virus load. Quantification of results of samples using different combinations of primers were compared using standard parametric and non-parametric tests. For analysis of plasma quantification results, the Pearson correlation coefficient was calculated. For the comparison of quantification results from PBMCs and subsets, which contained a large number of negative values, the non-parametric Spearman correlation coefficient was calculated.
HCV genotyping. HCV genotyping was performed by RFLP analysis of amplified PCR products from the NCR region of the virus (Davidson et al., 1995) . Patients 1, 2, 3, 4, 7, 8 and 9 were infected with genotype 1 and patients 5, 6 and 10 were infected with genotype 3.
DNA sequencing of PCR products. Positive samples from the strand-specific analysis of liver biopsies were reamplified from the primary product with one of the inner primers biotinylated. Single strand DNA was obtained using streptavidin-coated paramagnetic beads followed by alkaline denaturation, and dideoxy-termination sequencing reactions were performed using the Sequenase sequencing kit (US Biochemical) according to the manufacturer's instructions to confirm the specificity of the product.
Results
Sensitivity and specificity of the strand-specific RT-PCR assays
Synthetic viral RNA transcripts corresponding to the positive and negative strands of part of the HCV nucleocapsid region and part of the GBV-C\HGV NS3 region were synthesized from cloned plasmid DNA. Tenfold serial dilutions of these transcripts enabled us to determine the sensitivity limits of each primer combination for each strand of each virus ( Fig. 1 a and b for HCV and GBV-C\HGV respectively). Amplification conditions were highly stringent (see Methods) to maximize the specificity of the assays. The assays were carried out using the newly designed tagged primer combinations, the tag added to the 5h end of the outermost primers, the sequence of which is unrelated to HCV or to GBV-C\HGV, and simultaneously using the conventional untagged primers to determine if the tagging system had any effect on the sensitivity of the assays. The tag was incorporated in order to avoid the non-specific synthesis of cDNA by self-priming from fragments of nucleic acid in the extracted RNA sample. The presence of residual plasmid DNA was determined by PCR analysis omitting the reverse transcription step. Amplification of the transcripts was carried out under each set of conditions, i.e. the negative strand of HCV core was amplified using the conditions specific for negative strand detection as well as those specific for positive strand detection and conventional PCR to determine the sensitivity and specificity of the assays. In each case, the strand-specific detection system designed to identify either the positive or negative strand was more specific for that template than for the opposing strand (Fig. 1 a) . Non-specific detection of the opposite strand could in all experiments be attributed to residual plasmid DNA as the nucleic acid amplified without RT. Overall, the tagging system was as sensitive, within a factor of 10, as conventional PCR. A further set of controls was carried out to determine if cellular RNA could interfere with the modified detection system (Fig. 1 c) . Viral RNA was spiked with HCV\GBV-Cnegative cellular RNA equivalent to that tested in clinical specimens, prior to cDNA synthesis for conventional and tagged PCR to mimic the condition for analysis of PBMCs and liver extractions. If cellular nucleic acids had contributed to false priming events for either the conventional or the strandspecific assays, positive signals may have been detected in the ' jcellular RNA ' row. However, the sensitivities of the assays were not affected by the presence of cellular nucleic acids as positive signals were detected at identical end-points for both detection systems with or without the presence of cellular RNA (Fig. 1 c illustrates results obtained for HCV) .
Comparison of RNA quantification methods
Samples for the detection of HCV and GBV-C\HGV positive and negative strands were quantified using primers from 5hNCR and untagged primers from the core region of HCV, and NS3 region of GBV-C\HGV. Estimated HCV virus loads in PBMC subsets using 5hNCR primers range from 128 000-194 copies per 10' cells compared with 2460-194 copies per 10' cells using primers from the core region. There was a strong correlation between quantification results using two sets of primers (n l 46, R l 0n803, P 0n001). Similarly, there was a strong correlation using untagged core with the results of tagged primers used to detect positive strand RNA (n l 46, R l 0n704, P 0n001). These concordant results indicate that the main target sequence within the various cell types is likely to be positive strand RNA and that tagged primers from the core region were similarly sensitive for HCV as were those for untagged core and 5hNCR.
The same analysis was carried out comparing quantification of GBV-C\HGV sequences in PBMCs and liver using primers for 5hNCR and NS3 (tagged and untagged). In this case, a strong correlation between the results was observed (5hNCR vs untagged NS3, n l 42, R l 0n862, P 0n001 ; and NS3 untagged vs tagged NS3, n l 42, R l 0n880, P 0n001). Finally, quantification results using the various primers for HCV and GBV-C\HGV were compared for plasma. For HCV virus loads of 2n1i10(-8n3i10& copies\ml plasma (5hNCR) compares to 2n1i10(-1n65i10& copies\ml (untagged core) (n l 10, R l 0n955, P 10 −$ ). A similar strong correlation for the core tagged and untagged primers was observed (n l 10, R l 0n986, P 10 −$ ). For GBV-C\HGV, the following correlations were observed : NCR vs NS3, n l 29, R l 0n619, P 10 −$ ; untagged NS3 vs tagged NS3, n l 29, R l 0n534, P 0n002.
Strand-specific PCR on biological samples : liver biopsy RNA
The strand-specific PCR assays, having been validated using the synthetic RNA transcripts, were used to perform a similar set of PCR amplifications on RNA extracted from liver biopsy material, as described above, to determine if the liver, already known to be a site of replication for HCV, was also a site of GBV-C\HGV replication. Detection of single strands and conventional PCR for both viruses were done simultaneously to eliminate the possibility of further degradation of viral RNA on repeated freeze-thaw cycles. Semi-quantitative PCR analysis was also carried out on these samples. Positive and negative strands were detected for HCV, with lower levels of the replicative form than the genomic or positive strand form in agreement with previous observations (Table 2 a) . However, only relatively low frequencies of positive strands were detected for GBV-C\HGV in the liver of some patients, notably lower than the levels for HCV, and even though the levels of virus in plasma from all the patients were relatively high (Table 2 b) . The positive PCR products from each amplification system were then sequenced to ensure that the products were in fact viral in origin and not due to false priming with cellular RNA. These data confirmed that the products amplified were from viral nucleic acid. 
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Strand-specific PCR on biological samples : sub-populations of PBMCs
In order to investigate whether PBMCs were a significant extra-hepatic reservoir for HCV and GBV-C\HGV, we analysed sub-populations of PBMCs and sera from six HCVpositive individuals, two of which were also GBV-C\HGV RNA-positive, using the ER separation technique described in Methods. For HCV analysis the 5hNCR and partial core region were amplified by conventional PCR along with strand-specific PCR, also based on the core region, using the tagging system previously described. The results for the strand-specific PCR are shown in Table 3 (a). There was no overall pattern in the frequency of detection of HCV sequences amongst the subpopulations of the circulating PBMCs apart from a consistent absence of HCV in either the positive or negative form in CD4 (T helper) and CD8 (cytotoxic) T cells in all six patients studied. However, HCV RNA was detected in the nonrosetting fraction in varying amounts with each patient. Low frequencies of negative strands were detected in cells expressing CD4 and DR from P5, consistent with infection of dendritic cells. They also appeared in the plasma of one patient (P2).
The ER method leads to substantial loss of cells, and a further set of experiments was carried out using a different method where subsets of PBMCs from a further four HCVinfected individuals were directly separated by positive selection using antibody-coated beads, i.e. to select the CD14-positive fraction, PBMCs were incubated with anti-CD14-coated magnetic beads and isolated from the CD14-negative cells using a MiniMACS column. The depleted cells were sequentially incubated with anti-CD19-, anti-CD4-and finally anti-CD8-coated beads and the positively selected cells stored. Aliquots of the selected cells were used for FACS analysis and the remainder for HCV PCR analysis as described above. This method of fractionation gives highly pure populations of cells with a higher yield than the ER method (see Methods). The HCV PCR results obtained from cells separated using this technique (Table 3 b) confirmed the presence of positive strands of HCV in CD19-positive cells, i.e. B cells, in three out of four individuals. However, in contrast to the previous set of observations, one individual had genomic or positive strands in CD8 lymphocytes, although at low levels. The results, however, confirmed the previous observation that there were no negative strands nor replicative intermediates present in these subsets of PBMCs in any individual.
Plasma and PBMCs from a cohort of 20 GBV-C\HGV-infected individuals were analysed using the GBV-C\HGV NS3 strand-specific PCR assay (Table 4) . Although relatively high levels of circulating virus were detected in plasma, only some PBMC samples contained positive strand GBV-C\HGV viral RNA. No negative strand or replicating forms of the virus were detected. Two of the ten HCV-infected patients, P1 and P2, were coinfected with GBV-C\HGV, and the same subsets of PBMCs were analysed using the GBV-C\HGV NS3 strandspecific PCR assay. However, no replicating forms of the virus were detected in any subset of PBMCs.
Discussion
This study investigated whether extra-hepatic replication of HCV and now the novel HGV or GBV-C virus occurs in PBMCs. Although several methods for the detection of negative strand RNA have been developed, many may give false positive results due to a lack of strand specificity. Most of these assays are based on amplification of 5hNCR which, through its internal RNA folding, may lead to false positives in the detection of negative strands due to false priming events (McGuinness et al., 1994) . Lanford et al. (1994) attempted to resolve these specificity problems by introducing a tag sequence to the 5h end of the cDNA primers. The tag sequence is unrelated to HCV, and that sequence along with the opposing sense primer is used for PCR amplification, thereby circumventing the amplification of falsely primed cDNA products. Chaves et al. (1994) simultaneously developed a similar method for strand-specific detection of hepatitis A virus. Subsequently, Lerat et al. (1996) compared the strand specificity of three different RT-PCR assays using both synthetic and biological RNA templates. They compared conventional 5hNCR primers, tagged 5hNCR primer and core primers. They found that, although the tag increased the strand specificity of the assays based on the NCR, the overall specificity was lower than using untagged primers in the core region. We have independently confirmed these observations but have found the use of core primers in combination with the tag primer reduced further non-specific priming to undetectable levels (Fig. 1 a) . We have applied the same methodology to GBV-C\HGV and have developed a highly stringent strandspecific PCR assay based on the NS3 region of the virus (Fig.  1 b) .
These assays were used to detect positive and negative strands of HCV RNA in the liver, an established replication site of this virus, and to determine whether it was also a site of replication for GBV-C\HGV. Surprisingly, we found no evidence for replication of GBV-C\HGV virus in liver biopsies of the 13 infected individuals tested, despite the presence of high levels of circulating virus in plasma. However, these findings are consistent with recent studies that suggest that GBV-C\HGV is not associated with clinically evident liver disease (Masuko et al., 1996 ; Wang et al., 1996 ; Alter, 1996) . They are also consistent with observations of much lower levels of GBV-C\HGV viral RNA compared with those of HCV (Kudo et al., 1997) and the failure to detect negative strands of the virus in liver tissue (Laskus et al., 1997) . Furthermore, although HGV was originally cloned from a patient with chronic non-A, non-B hepatitis (Linnen et al., 1996) , it was subsequently shown that this individual was coinfected with HCV, the likely cause of the hepatitis. On the other hand, HGV was also recovered from a second individual with intermittently abnormal ALT elevation in the absence of HCV co-infection, to which HGV may have contributed. More definitive evidence for a lack of involvement of GBV-C\HGV in chronic hepatitis is the observation that the frequency of infection of blood donors with abnormal ALT levels (11\709 ; 1n6 %) was similar to those with normal levels (13\769 ; 1n7 %).
Several investigators have reported the detection of HCV replicative or negative strand RNAs in PBMCs (Lerat et al., 1996 ; Willems et al., 1993 ; Navas et al., 1994 ; Muller et al., 1993 ; Gil et al., 1993 ; Gabrielli et al., 1994) . A recent study by Muratori et al. (1996) describes the strand-specific detection of HCV in PBMCs using in situ RT-PCR ; 86 % of PBMCs from the patients that contained positive strands also contained negative strand intermediates when using a tagged sense NCR primer for negative strand detection. The authors conclude that replication of HCV in PBMCs is a common occurrence. However this assay and most others used above used primers from the 5hNCR and may have generated false positive results (see above). In the ten chronically HCV-infected individuals in this study, only putative dendritic cell populations from one patient contained replicative forms of the virus. In the remaining nine patients, no negative strands could be detected in any PBMC subfraction, even though the levels of positive strands ranged from 1n67i10&-2n1i10( HCV copies\ml in plasma and between 12 800-194 copies per 10' cells in PBMC subsets. HCV replication in PBMCs therefore must occur at substantially lowers levels than in liver, if at all, particularly given the relative number of cells in the liver in comparison to that of the lymphoid system, and is therefore unlikely to be a significant reservoir of HCV infection in vivo.
PBMC samples from a further 20 GBV-C\HGV-infected individuals were tested with relatively high levels of circulating virus. Although positive strands were detected in some patients, no negative strands were observed, suggesting that GBV-C\HGV not only does not infect the liver to any significant extent but does not infect PBMCs either. There still remains the possibility that GBV-C\HGV could replicate in these sites, although if they do so, it would be at a level so low that detection is beyond the sensitivity of these assays.
In one patient, P2, a low level of negative strand RNA was detected in plasma for HCV (6n67-10$ copies\ml). This may indicate a limitation to the specificity of the detection of negative strands using the core tagged primers, as there were approximately 3 000 times more positive strands detected in the same sample. Our ability to demonstrate the specificity of the assay using transcripts was limited by the residual presence of plasmid DNA. However, greater than four orders of magnitude separated the end-points of the positive and negative strand RNA titrations in both positive and negative strand assays for HCV RNA, indicating that the detection of negative strands in plasma was not due to a failure of the assay. It has been suggested that negative strands of HCV RNA in the form of replicating complexes may be released from liver (Shindo et al., 1994 ; Fong et al., 1991 ; Lanford et al., 1995) .
In conclusion, our findings indicate that HCV replication in PBMCs is a rare event as only one out of ten HCV carriers studied appears to contain replicating virus. The novel HGV or GBV-C virus does not appear to be hepatotropic nor was there any evidence for its replication in circulating PBMCs.
